Eltrombopag is a small-molecule agonist of the c-mpl (TpoR) receptor, developed as a pharmaceutical active ingredient for conditions involving abnormally low platelet counts. It is a hydrazine derivative featuring a biphenyl carboxylic acid and a pyrazolone moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Eltrombopag?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Eltrombopag olamine
pharmaceutical raw material
Eltrombopag Amide
pharmaceutical raw material
Eltrombopag Methyl Ester
pharmaceutical raw material
Methoxy Eltrombopag
pharmaceutical raw material
Algestone acetonide
pharmaceutical raw material
DL-dobutamine hydrochloride
pharmaceutical raw material
Garamine
pharmaceutical raw material
1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol
pharmaceutical raw material
The international HS code for Eltrombopag (CAS 496775-61-2) is 2933.19.
2933.19
2933 19 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid
SVOQIEJWJCQGDQ-UHFFFAOYSA-N
CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C
Sourcing Eltrombopag?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.